CSF concentrations of neurogranin are increased in Alzheimer’s disease, but not in other neurodegenerative disorder such as Parkinson’s disease, frontotemporal dementia, Lewy body dementia, progressive supranuclear palsy, or multiple system atrophy. This evidence concerns the gene NRGN and Alzheimer disease.